Our Story
-
2021-01-01Strategic Partnering and Fund-raising
In 2021, Pulxion achieved the recognition of being one of the 'Top 100 Startups in Taiwan' by CES and ranked among the 'Top 10 Startups in Taiwan' by Silicon Valley's StartupCity magazine. Throughout 2022, we gained media recognition around the globe, including US News coverage from the mainstream. As of the third quarter of 2023, we've successfully secured angel funding and solidified our core management team. These new developments have poised us for forging strategic partnerships and engaging with investors to power our future growth. -
2020-06-15Pulxion Medical Technology Founded
The entity preceding Pulxion Medical Technology was selected into the New Industry-Academia-Research Collaboration Plan, also known as the "Value Creation Programs for Start-up Teams in Universities (VCPSTU)," in November 2019 by the Ministry of Science and Technology in Taiwan. Alongside the financial backing provided by the government for a period of one and a half years, we also leveraged the resources furnished by the Taiwan Startup Institute (TSI) accelerator. In 2020, Pulxion Medical Technology was officially founded with the mission of advancing this novel technology towards commercialization. -
2016-06-01Technology Inception
Pulxion Medical Technology, founded in 2020, traces its innovative roots back to the collaborative efforts of Professor Herbert Hsiao and Dr. Hsien-Li Kao from 2014. Our core concept is grounded in the understanding that carotid artery stenosis changes the blood hemodynamics, giving rise to distinctive pulsation patterns on the body surface.
By applying AI and advanced image processing techniques, we've harnessed this concept to develop PulStroke®, a revolutionary technology for evaluating carotid artery stenosis and providing quick results aligned with ultrasound standards. Our unwavering dedication to excellence has earned us several prestigious National Innovation Awards in Taiwan and the IDA International Design Award in the United States.